Moody Aldrich Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-1,228
Closed -$234K – 180
2020
Q2
$234K Sell
1,228
-29,166
-96% -$5.11M 0.05% 150
2020
Q1
$4.71M Sell
30,394
-5,813
-16% -$676K 1.42% 23
2019
Q4
$3.03M Buy
36,207
+654
+2% +$49.8K 0.62% 69
2019
Q3
$2.41M Sell
35,553
-392
-1% -$25.8K 0.64% 63
2019
Q2
$2.39M Sell
35,945
-34,324
-49% -$2M 0.61% 67
2019
Q1
$3.91M Buy
70,269
+10,772
+18% +$658K 1.1% 42
2018
Q4
$2.95M Buy
59,497
+18,164
+44% +$1.11M 0.97% 46
2018
Q3
$3.57M Buy
+41,333
New +$2.95M 1.03% 42

Other funds holding TDOC

Moody Aldrich Partners's TDOC Position: Q3 2020 in Review

Moody Aldrich Partners sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 1,228 shares — an estimated $234K sold.

Moody Aldrich Partners first reported a position in TDOC in Q3 2018 and held it in 8 quarters. The position peaked at $4.71M in Q1 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • Moody Aldrich Partners reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
  • Moody Aldrich Partners sold 1,228 Teladoc Health shares in Q3 2020, an estimated $234K.
  • Moody Aldrich Partners first reported a position in Teladoc Health in Q3 2018 and held it in 8 quarters.
  • Moody Aldrich Partners's Teladoc Health position peaked at $4.71M in Q1 2020.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Moody Aldrich Partners's 13F filing for Q3 2020, filed 12 Nov 2020.